Status:
COMPLETED
Disability, MRI Lesions and Thickness of Retinal Fibers: Evaluation 15 Years After a First Episode of Demyelination
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Multiple Sclerosis
Pathologic Processes
Eligibility:
All Genders
Brief Summary
Knowledge of the evolution of multiple sclerosis (MS) and its long-term prognostic factors is essential to guide the therapeutic management. However, it remains partial and concerns above all data col...
Eligibility Criteria
Inclusion
- First episode of demyelination occurred at least 10 years ago
- Hospitalized in the neurology department during this episode
- Insured with a social security scheme
- Having given his consent to participate in the study
Exclusion
- Contraindications to 3 Tesla MRI and injection of contrast media
- Benefiting from a legal protection measure
- Pregnant or nursing mother
Key Trial Info
Start Date :
May 3 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 3 2021
Estimated Enrollment :
182 Patients enrolled
Trial Details
Trial ID
NCT03268096
Start Date
May 3 2017
End Date
November 3 2021
Last Update
April 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondation Ophtalmologique A. de Rothschild
Paris, France